Will FDA approve any mRNA vaccine against squamous cell carcinoma before 2028?
Sağlık ve TıpOne-Off1y
Manifold MarketsKYC yokDoğrulanmış sonuçlanma verisiOrta düzey kalibreGüncel topluluk tahminiHayır 64.9%
Tahminciler
8
Soru türü
binary
Yöntem
Play-money forecasting platform
Kaynak türü
Tahmin
Piyasa verileri
23 dakika önce güncellendi
21 Şub 23 20:21 UTC31 Ara 27 22:59 UTC
Trendler
Kurallar
Resolves YES if the FDA grants full approval for the commercial sale of any mRNA-based vaccine for the treatment of squamous cell carcinoma in the United States before January 1, 2028.
- This does not include emergency use authorization or other forms of limited authorization.
- Resolves NO otherwise.
